After ACIP Gambit, Pfizer, GSK Take RSV Vaccines To US FDA Adcomm

 
• By Sarah Karlin-Smith and Bridget Silverman
  
RSV virus
ACIP members preferred a higher age floor for the RSV vaccines in older adults. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet